Cargando…
Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
Benzodiazepines (BZDs) and Z-drugs are compounds widely prescribed in medical practice due to their anxiolytic, hypnotic, and muscle relaxant properties. Yet, their chronic use is associated with cases of abuse, dependence, and relapse in many patients. Furthermore, elderly people are susceptible to...
Autores principales: | Ettcheto, Miren, Olloquequi, Jordi, Sánchez-López, Elena, Busquets, Oriol, Cano, Amanda, Manzine, Patricia Regina, Beas-Zarate, Carlos, Castro-Torres, Rubén D., García, Maria Luisa, Bulló, Mónica, Auladell, Carme, Folch, Jaume, Camins, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960222/ https://www.ncbi.nlm.nih.gov/pubmed/31969812 http://dx.doi.org/10.3389/fnagi.2019.00344 |
Ejemplares similares
-
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
por: Folch, Jaume, et al.
Publicado: (2019) -
The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia
por: Folch, Jaume, et al.
Publicado: (2018) -
Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
por: Folch, Jaume, et al.
Publicado: (2018) -
Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
por: Ettcheto, Miren, et al.
Publicado: (2017) -
Current Research Therapeutic Strategies for Alzheimer's Disease Treatment
por: Folch, Jaume, et al.
Publicado: (2016)